Announcements Trials

Browse Landscape

Phase

Status

Terminated 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Hand-Foot Syndrome 1

Interventions

Cyclophosphamide 390 Carboplatin 343 Gemcitabine 331 pembrolizumab 330 Cisplatin 327 Paclitaxel 295 Radiotherapy 292 Docetaxel 286 Bevacizumab 249 Rituximab 233 Capecitabine 222 Nivolumab 220 Dexamethasone 205 Fluorouracil 189 fludarabine 178 Oxaliplatin 177 Pemetrexed 153 Doxorubicin 152 Irinotecan 147 Etoposide 144 Leucovorin 143 Cytarabine 134 fludarabine phosphate 129 Bortezomib 129 Cetuximab 127 Lenalidomide 125 Filgrastim 120 Erlotinib Hydrochloride 119 Temozolomide 111 Ipilimumab 111

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Interventional × Brimonidine Tartrate × Clear all

NCT03173365 2019-01-09

BRIMOCAN

Heinrich-Heine University, Duesseldorf

Phase 2 Terminated

Hand-Foot Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡